AstraZeneca’s building in Luton, Britain.
AstraZeneca and the University of Oxford are defending the results and methods used in their phase three vaccine trials on the back of criticism from expert… [read more]
AstraZeneca’s building in Luton, Britain.
AstraZeneca and the University of Oxford are defending the results and methods used in their phase three vaccine trials on the back of criticism from expert… [read more]